Baseline sCD40L levels were measured in 3044 consecutive patients with acute minor stroke and transient ischemic attack , who had previously been enrolled in the Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events ( CHANCE ) trial .